Browsing: Weight Loss

CMS administrator Dr. Mehmet Oz discusses the role of GLP-1 medications in combating obesity, saying they can support better health when combined with lifestyle changes and medical guidance

BMJ study says weight loss drugs have limited heart health benefits in 1st year: Expert says too soon for a final verdict | Health and Wellness News – The Indian Express skip to content

Most weight-loss drugs do not meaningfully improve quality of life and few show improvements to heart health after a year, a new analysis has found

Millions of Medicare beneficiaries could save tens of thousands a year as the Feds make a multibillion dollar bet that slimming elders’ waistlines could lighten the burden of Medicare’s costs — eventually

Effective weight management must be seen in the round, not reduced to a blister pack, writes Dr Mitra Dutt

A record number of Americans are taking GLP-1 drugs for weight loss, according to a new Gallup survey released Tuesday — a massive increase over the past two years. 

GLP-1 coverage trends force Canadian benefits insurers to rethink plan design | Insurance Business

India, July 9, 2026 /PRNewswire/ — India is approaching a pivotal moment in the evolution of obesity and metabolic health management. As awareness grows among healthcare professionals and patients alike, the obesity care ecosystem is rapidly transitioning from reactive treatment toward proactive and long-term disease management

SINGAPORE, July 8, 2026 /PRNewswire/ — Novo Nordisk announced an update to the Singapore label for semaglutide, approved in Singapore as Wegovy® (semaglutide) injection, incorporating clinical evidence from the STEP UP trial in adults living with obesity without diabetes. In the trial, which evaluated a higher dose of semaglutide (7.2 mg), up to one in three…

New research indicates that Wegovy pills are as effective as their injectable counterparts for weight loss, though they may not deliver the same heart health benefits